---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-036794"
form_type: "8-K"
ticker: "CTMX"
cik: "0001501989"
company_name: "CytomX Therapeutics, Inc."
filed_at: "2025-02-26T23:59:59+00:00"
generated_at: "2026-05-26T03:30:55.899155+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CytomX receives Nasdaq delisting notice for bid price non-compliance

## Summary
- Nasdaq notified CytomX on Feb 24, 2025 that common stock bid price stayed below $1.00 for 30 consecutive business days through Feb 21, 2025.
- Company has 180 calendar days, until August 25, 2025, to regain compliance by closing at $1.00 for 10 consecutive business days.
- If not cured by the deadline, CytomX may transfer to Nasdaq Capital Market for an additional 180-day compliance period.
- Company will monitor bid price and consider options, but there is no assurance of regaining compliance.

## SEC filing metadata
- accession: 0001193125-25-036794
- form_type: 8-K
- ticker: CTMX
- cik: 0001501989
- company_name: CytomX Therapeutics, Inc.
- filed_at: 2025-02-26T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501989/000119312525036794/0001193125-25-036794-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501989/000119312525036794/d891467d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-036794
- JSON: https://secwatch.observer/filing/0001193125-25-036794.json
- Plain text: https://secwatch.observer/filing/0001193125-25-036794.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.